A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study To Evaluate The Efficacy And Safety Of Seltorexant 20 Mg As Adjunctive Therapy To Antidepressants In Adult And Elderly Patients With Major Depressive Disorder With Insomnia
Posted Date: Jun 22, 2021
- Investigator: Susan Lynn Mcelroy
- Specialties: Depression, Psychiatry/Psychology
- Type of Study: Drug
This study is being conducted to investigate the antidepressant effects of an investigational medication (versus placebo), as add on treatment to an antidepressant medication in adults (18 to 64 years, inclusive) and elderly (65 to 74 years, inclusive) with major depression, and particularly in those with major depressive disorder with insomnia symptoms, who have had an inadequate response to treatment with an SSRI/SNRI (a common type of antidepressant medication treatment).
Basic Entry Criteria: 1. Male Or Female, Aged 18 To 74 Years (Inclusive). 2. Meet Dsm-5 Diagnostic Criteria For Major Depression, Without Psychotic Features, Based Upon Clinical Assessment With First Depressive Episode Prior To Age 60. The Length Of The Current Depressive Episode Must Be Less Than Or Equal To 18 Months. 3. Have Had An Inadequate Response To At Least 1 But No More Than 2 Antidepressants, Administered At An Adequate Dose And Duration In The Current Episode Of Depression.
Depression, Major Depression
For More Information: